Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Aug;43(8):713-7.
doi: 10.1016/j.exphem.2015.02.007. Epub 2015 Apr 23.

Drug Discovery in Academia

Affiliations
Review

Drug Discovery in Academia

Aisha Shamas-Din et al. Exp Hematol. .

Abstract

Participation of academic centers in aspects of drug discovery and development beyond target identification and clinical trials is rapidly increasing. Yet many academic drug discovery projects continue to stall at the level of chemical probes, and they infrequently progress to drugs suitable for clinical trials. This gap poses a major hurdle for academic groups engaged in drug discovery. A number of approaches have been pursued to overcome this gap, including stopping at the production of high-quality chemical probes, establishing the resources in-house to advance select projects toward clinical trials, partnering with not-for-profit groups to bring the necessary resources and expertise to develop probes into drugs, and drug repurposing, whereby known drugs are advanced into clinical trials for new indications. In this review, we consider the role of academia in anticancer drug discovery and development, as well as the strategies used by academic groups to overcome barriers in this process.

Similar articles

See all similar articles

Cited by 1 article

Publication types

Substances

LinkOut - more resources

Feedback